(Q61909736)

English

Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Randomised Double Blind Placebo Controlled Multicenter Study for Evaluation of Clinical Efficacy and Safety of Ingavirin 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults. (English)

0 references

medical condition

common cold

0 references

main subject

Acute Respiratory Viral Infection in Children: Modern Approaches to Diagnosis and Treatment

0 references

start time

January 2010

0 references

end time

April 2014

0 references

number of participants

445

0 references

clinical trial phase

phase IV clinical trial

0 references

research subject recruitment status

completed

0 references

minimum age

18 year

0 references

maximum age

60 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03154515

0 references

(Q61909736)

Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)